SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001615774-17-003293
Filing Date
2017-06-21
Accepted
2017-06-21 17:00:41
Documents
1
Period of Report
2017-06-20

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT - CHARLES E. MATHER IV s106635_form4.html 4  
1 OWNERSHIP DOCUMENT - CHARLES E. MATHER IV s106635_form4.xml 4 3924
  Complete submission text file 0001615774-17-003293.txt   5457
Mailing Address 509 MADISON AVE. - SUITE 306 NEW YORK NY 10022
Business Address 509 MADISON AVE. - SUITE 306 NEW YORK NY 10022 1-800-849-7894
Tonix Pharmaceuticals Holding Corp. (Issuer) CIK: 0001430306 (see all company filings)

IRS No.: 261434750 | State of Incorp.: NV | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O TONIX PHARMACEUTICALS HOLDING CORP 509 MADISON AVE., SUITE 306 NEW YORK NY 10022
Business Address
MATHER CHARLES E IV (Reporting) CIK: 0001563422 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36019 | Film No.: 17923365